(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

COMPOSIÇÕES DE PROTOPARVOVÍRUS E TETRAPARVOVÍRUS E MÉTODOS PARA TERAPIA GÊNICA

ArquivadaInvention PatentPCT · US2021065108
Talk to an expert

Application data

Number

112023012293

Type

Invention Patent

Filing

12/23/2021

Publication

02/15/2024

PCT

US2021065108
View on INPI

Progress at the INPI

  1. Filing12/23/21
  2. Publication02/15/24
  3. Abandoned
  4. Allowance
  5. Grant
  6. In force

The application was abandoned: examination was not requested within the 36 months following the 12/23/2021 filing, the deadline set by art. 33 of the Brazilian IP Act. The technology is in the public domain in Brazil.

Talk to a specialist

Latest action published by the INPI: 03/18/2025. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

SYNTENY THERAPEUTICS, INC.

US

Inventors

R. K. (pessoa física)

US

S. A. (pessoa física)

US

Technical data

IPC Classification

A61K 35/76A61K 39/00C12N 15/09C12N 15/864C12N 7/00

Priority claims

US

63/129,848 · 12/23/2020

Abstract

COMPOSIÇÕES DE PROTOPARVOVÍRUS E TETRAPARVOVÍRUS E MÉTODOS PARA TERAPIA GÊNICA. A presente invenção refere-se a vírions recombinantes que têm uma proteína de capsídeo, ou uma variante da mesma, de um protoparvovírus ou tetraparvovírus, e um ácido nucleico que inclui um ácido nucleico heterólogo.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Arquivamento definitivo - Art. 33 da LPI

#11.1.1

03/18/2025

RPI 2828

Arquivamento - Art. 33 da LPI

#11.1

12/31/2024

RPI 2817

Notificação de entrada na fase nacional - PCT

#1.3

02/15/2024

RPI 2771

Alteração de dados cadastrais

#1.1

06/27/2023

RPI 2738

Related

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.